Tirzepatide injection is used to help lose weight and keep the weight off in patients with obesity caused by certain conditions.
Tirzepatide is used for type 2 diabetes to help improve blood sugar levels. In type 2 diabetes, tirzepatide decreases blood sugar levels by helping release insulin when blood sugar levels are high, lowering the amount of sugar the liver makes, and slowing food movement through the intestines.
Tirzepatide should be used together with diet and exercise.
Glucagon-like peptide-1 (GLP-1) is a hormone made up of 30 amino acids that comes from the endocrine cells in the intestines. It belongs to a group of hormones called incretins, which help increase insulin production. Glucose-dependent insulinotropic polypeptide (GIP) is another incretin that impacts insulin production.
What Is The Difference Between Tirzepatide and Semaglutide?
Semaglutide and tirzepatide are both in the class of drugs known as incretin mimetics and work similarly but have some differences in mechanism and dosing. Both drugs are FDA approved in various brand names as treatments for type 2 diabetes and long-term weight loss.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and mimics the natural GLP-1 hormone in our bodies. It binds to the GLP-1 receptor to exert its effect.
Tirzepatide is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and also glucagon-like peptide-1 (GLP-1) receptor agonist and binds to both GIP and GLP-1 receptors. Like GLP-1, GIP is also a natural incretin hormone and may increase the action of tirzepatide.
